PHOENIX, March 08, 2018 (GLOBE NEWSWIRE) — INSYS Therapeutics, Inc. (NASDAQ:INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today reported financial results for its fourth quarter and full year ended Dec. 31, 2017. Read More
The post INSYS Therapeutics Reports Fourth Quarter and Full Year 2017 Results appeared first on Dagga Magazine.